rheumatoid arthritis, lupus nephritis, polymyositis/dermatomyositis with interstitial pneumonia, ulcerative colitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Autoimmune Disease Patients (with rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis / polymyositis, mixed connective tissue disease or ulcerative colitis) who are taking Tacrolimus with 3mg/day or more but the trough levels of serum tacrolimus concentration did not reach the minimal effecive range.
Exclusion criteria
Exclusion criteria: patients who do not satisfy the classification criteria of each disease and those who do not wish to perticipate in this clinical test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increase of tacrolimus blood concentration | — |
Countries
Japan
Contacts
Kyoto University Department of Rheumatology and Clinical Immunology